Although the immune signature of NAFLD is not the main topic of this review, it is noteworthy to mention a recent study in humans showing a direct correlation between circulating and hepatic cytotoxic CD8+ T lymphocytes and histological hallmarks of NASH66 that might serve as potential biomarker for NAFLD patient’s stratification. This evidence concerns the gene CD8A and metabolic dysfunction-associated steatotic liver disease.